# Mechanisms of Brain Hypoperfusion in AD/ADRD (R01 Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/rfa-ag-23-014-mechanisms-of-brain-hypoperfusion-in-ad-adrd-r01/  
Official notice: https://www.grants.gov/search-results-detail/338247

> National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on July 1, 2022.

| Field | Value |
|---|---|
| Opportunity number | RFA-AG-23-014 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | July 1, 2022 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.866 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

## What the grant funds

This Funding Opportunity Announcement (FOA) solicits applications for projects designed to understand molecular and cellular mechanisms underlying cerebral blood flow reduction in Alzheimers disease (AD) and Alzheimers disease-related dementias (ADRD).

## Questions people ask

### Is RFA-AG-23-014 still open?

No. It closed on July 1, 2022.

### Who can apply for Mechanisms of Brain Hypoperfusion in AD/ADRD (R01 Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Mechanisms of Brain Hypoperfusion in AD/ADRD (R01 Clinical Trial Not Allowed)?

Closed July 1, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under RFA-AG-23-014?

NIH RePORTER lists 11 projects funded under RFA-AG-23-014 in fiscal 2023 to 2026, at 10 institutions. The most were at University of Texas HLTH Sci Ctr Houston, University of Nevada Reno, Medical University of South Carolina.

### Who has won Aging Research grants before?

The largest recipients over five fiscal years were The Regents of the University of California, San Francisco, The Trustees of Columbia University in the City of New York, University of Southern California. The program made 11,026 awards worth $19 billion in that time.